Get all your news in one place.
100's of premium titles.
One app.
Start reading
Newcastle Herald
Newcastle Herald
National
Damon Cronshaw

Jobs set to go and cancer treatments slashed in tough federal research cuts

A Newcastle biotech company is set to lose more than $6 million a year in cuts to research and development tax incentives proposed by the Albanese government.

ImmVirX, which has a research and development arm in Newcastle, runs clinical trials of immunotherapy for patients with colorectal and ovarian cancer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.